Pfizer also did well with oncology drugs such as Ibrance and Xtandi.

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...

MINNEAPOLIS — After more than 13 billion COVID vaccines given around the world, the largest studies to date point to the ...

Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment ...

The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...

All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their ...

Pfizer raised its annual profit forecast and reported first-quarter results that exceeded Wall Street’s expectations, driven ...

71.3%. The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

US stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two ...

Pfizer-BioNTech’s and Moderna’s mRNA-based COVID ... under an FDA priority review. Krazati just recently joined BMS’ arsenal after the company bought its maker, Mirati Therapuetics, for up ...

Pfizer ( PFE-N) was up after lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped ...

Under health ministry regulations, Israeli youths can receive Pfizer shots but not yet those produced by Moderna. Israel has almost exclusively administered Pfizer shots to around 60% of its 9.3 ...